IntegraGen is a leader in genome analysis and the development and commercialization of molecular diagnostic tests for oncology.
Genomic Services
miRpredX 31-3p
Investors
Latest news // Archive
-
Press releases
The SeqOIA Cooperative Health Group selects IntegraGen as the operator of its sequencing platform as part of the France Genomic Medicine 2025 Plan
-
Press releases
IntegraGen Reports 17% Revenue Growth During First Half of 2018
-
News
GoPath Labs Announces North American Launch of miR-31-3p expression test